G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 109 filers reported holding G1 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $208,000 | +51.8% | 20,418 | +100.0% | 0.00% | – |
| Q3 2021 | $137,000 | -22.6% | 10,209 | 0.0% | 0.00% | – |
| Q2 2021 | $177,000 | -75.6% | 10,209 | -66.1% | 0.00% | -100.0% |
| Q1 2021 | $724,000 | +39.5% | 30,081 | +4.3% | 0.00% | 0.0% |
| Q4 2020 | $519,000 | +55.9% | 28,842 | 0.0% | 0.00% | – |
| Q3 2020 | $333,000 | -52.4% | 28,842 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $700,000 | +135.7% | 28,842 | +7.1% | 0.00% | 0.0% |
| Q1 2020 | $297,000 | -68.6% | 26,942 | -24.6% | 0.00% | 0.0% |
| Q4 2019 | $945,000 | +0.3% | 35,742 | -13.5% | 0.00% | 0.0% |
| Q3 2019 | $942,000 | -6.7% | 41,342 | +25.5% | 0.00% | -50.0% |
| Q2 2019 | $1,010,000 | +41.9% | 32,950 | -23.2% | 0.00% | +100.0% |
| Q1 2019 | $712,000 | -12.5% | 42,891 | +0.9% | 0.00% | 0.0% |
| Q4 2018 | $814,000 | -66.7% | 42,491 | -9.1% | 0.00% | -75.0% |
| Q3 2018 | $2,444,000 | +72.1% | 46,743 | +43.1% | 0.00% | +100.0% |
| Q2 2018 | $1,420,000 | +48.4% | 32,668 | +26.4% | 0.00% | +100.0% |
| Q1 2018 | $957,000 | – | 25,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |